Cambria Investment Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Buy
6,420
+915
+17% +$190K 0.08% 230
2026
Q1
$1.16M Buy
5,505
+2,189
+66% +$471K 0.06% 211
2025
Q4
$680K Sell
3,316
-924
-22% -$174K 0.04% 298
2025
Q3
$663K Buy
4,240
+846
+25% +$131K 0.04% 293
2025
Q2
$568K Sell
3,394
-94
-3% -$14K 0.04% 229
2025
Q1
$479K Buy
+3,488
New +$445K 0.03% 181
2024
Q2
Sell
-6,192
Closed -$693K 350
2024
Q1
$693K Sell
6,192
-390
-6% -$42.1K 0.04% 165
2023
Q4
$663K Buy
6,582
+707
+12% +$70.1K 0.05% 155
2023
Q3
$507K Sell
5,875
-1,008
-15% -$91.1K 0.04% 168
2023
Q2
$651K Sell
6,883
-1,584
-19% -$134K 0.05% 156
2023
Q1
$639K Buy
+8,467
New +$639K 0.05% 169

Other funds holding CAH

Cambria Investment Management's CAH Position: Q2 2026 in Review

Cambria Investment Management increased its Cardinal Health (CAH) stake by 17% in Q2 2026, buying an estimated $190K and bringing the position to 6,420 shares worth $1.52M. The position accounts for 0.08% of the portfolio, ranked #230.

Cambria Investment Management first reported a position in CAH in Q1 2023 and has held it in 11 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Cambria Investment Management held 6,420 shares of Cardinal Health worth $1.52M as of Q2 2026.
  • Cambria Investment Management bought 915 Cardinal Health shares in Q2 2026, an estimated $190K.
  • Cardinal Health made up 0.08% of Cambria Investment Management's portfolio in Q2 2026, its #230 holding.
  • Cambria Investment Management first reported a position in Cardinal Health in Q1 2023 and has held it in 11 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.